All Stories

  1. Lurasidone in the Treatment of Bipolar Depression: Systematic Review of Systematic Reviews

    Article • BioMed Research International, January 2017, Hindawi Publishing Corporation

    Professor Giampaolo Robert Perna, Prof Andrea de Bartolomeis, Professor Domenico De Berardis

  2. Postsynaptic density protein transcripts are differentially modulated by minocycline alone or in add-on to haloperidol: Implications for treatment resistant schizophrenia

    Article • Journal of Psychopharmacology, July 2016, SAGE Publications

    Prof Andrea de Bartolomeis

  3. Switching antipsychotics: imaging the differential effect on the topography of postsynaptic density transcripts in antipsychotic-naïve vs. antipsychotic-exposed rats

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, May 2016, Elsevier

    Prof Andrea de Bartolomeis

  4. New advances in the treatment of generalized anxiety disorder: the multimodal antidepressant vortioxetine

    Article • Expert Review of Neurotherapeutics, April 2016, Taylor & Francis

    Professor Giampaolo Robert Perna, Prof Andrea de Bartolomeis

  5. P.1.009 Effects of caffeine, nicotine and their combination with haloperidol on PSD molecules: relevance to psychiatric diseases

    Article • European Neuropsychopharmacology, March 2016, Elsevier

    Prof Andrea de Bartolomeis

  6. Treatment resistant schizophrenia is associated with the worst community functioning among severely-ill highly-disabling psychiatric conditions and is the most relevant predictor of poorer achievements in functional milestones

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, February 2016, Elsevier

    Prof Andrea de Bartolomeis

  7. A comprehensive review on the efficacy of S-Adenosyl-L-methionine in Major Depressive Disorder.

    Article • CNS & Neurological Disorders - Drug Targets, January 2016, Bentham Science Publishers

    Professor Giampaolo Robert Perna, Prof Andrea de Bartolomeis, Professor Domenico De Berardis

  8. Targets, attitudes, and goals of psychiatrists treating patients with schizophrenia: key outcome drivers, role of quality of life, and place of long-acting antipsychotics

    Article • January 2016, Dove Medical Press

    Prof Andrea de Bartolomeis

  9. D-aspartate dysregulation in Ddo−/− mice modulates phencyclidine-induced gene expression changes of postsynaptic density molecules in cortex and striatum

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, October 2015, Elsevier

    Prof Andrea de Bartolomeis

  10. Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials

    Article • Current Drug Targets, September 2015, Bentham Science Publishers

    Prof Andrea de Bartolomeis, Professor Domenico De Berardis

  11. C.14.02 Second witness – impact on brain architecture

    Article • European Neuropsychopharmacology, September 2015, Elsevier

    Prof Andrea de Bartolomeis

  12. Update on the Mechanism of Action of Aripiprazole: Translational Insights into Antipsychotic Strategies Beyond Dopamine Receptor Antagonism

    Article • CNS Drugs, September 2015, Springer Science + Business Media

    Prof Andrea de Bartolomeis

  13. Palmitoylethanolamide reduces pain-related behaviors and restores glutamatergic synapses homeostasis in the medial prefrontal cortex of neuropathic mice

    Article • Molecular Brain, August 2015, Springer Science + Business Media

    Prof Andrea de Bartolomeis

  14. Increased Signaling via Adenosine A1 Receptors, Sleep Deprivation, Imipramine, and Ketamine Inhibit Depressive-like Behavior via Induction of Homer1a

    Article • Neuron, August 2015, Elsevier

    Dr Kenneth A. Jacobson, Prof Andrea de Bartolomeis

  15. Factor structure and reliability of the Italian adaptation of the Hypomania Check List-32, second revision (HCL-32-R2)

    Article • Journal of Affective Disorders, June 2015, Elsevier

    Professor Giampaolo Robert Perna, Prof Andrea de Bartolomeis

  16. Polarity-dependent effects of transcranial direct current stimulation in obsessive-compulsive disorder

    Article • Neurocase, May 2015, Taylor & Francis

    Prof Andrea de Bartolomeis

  17. Progressive recruitment of cortical and striatal regions by inducible postsynaptic density transcripts after increasing doses of antipsychotics with different receptor profiles: Insights for psychosis treatment

    Article • European Neuropsychopharmacology, April 2015, Elsevier

    Prof Andrea de Bartolomeis

  18. A Role for D-aspartate Oxidase in Schizophrenia and in Schizophrenia-related Symptoms Induced by Phencyclidine in Mice.

    Article • European Psychiatry, March 2015, Elsevier

    Prof Andrea de Bartolomeis

  19. Worse Comes to Worst in Schizophrenia: Treatment Resistant Schizophrenia Patients Show Greater Impairment in Functional Milestones of Everyday Living Compared to Other Psychiatric Disabling Conditions

    Article • European Psychiatry, March 2015, Elsevier

    Prof Andrea de Bartolomeis

  20. A role for D-aspartate oxidase in schizophrenia and in schizophrenia-related symptoms induced by phencyclidine in mice

    Article • Translational Psychiatry, February 2015, Nature

    Prof Andrea de Bartolomeis, MD, PhD Valeria D'Argenio

  21. Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression

    Article • International Journal of Molecular Sciences, January 2015, MDPI AG

    Professor Giampaolo Robert Perna, Prof Andrea de Bartolomeis

  22. MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine–Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective

    Article • Molecular Neurobiology, November 2014, Springer Science + Business Media

    Prof Andrea de Bartolomeis

  23. P.3.c.008 Immediate early and constitutive genes expression in antipsychotic switching paradigm: from clinical practice to animal model

    Article • European Neuropsychopharmacology, October 2014, Elsevier

    Prof Andrea de Bartolomeis

  24. Regulation of postsynaptic plasticity genes' expression and topography by sustained dopamine perturbation and modulation by acute memantine: Relevance to schizophrenia

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, October 2014, Elsevier

    Prof Andrea de Bartolomeis

  25. Towards a framework for treatment effectiveness in schizophrenia

    Article • September 2014, Taylor & Francis

    Professor Sergey Nikolaevich Mosolov, Prof Andrea de Bartolomeis

  26. The Glutamatergic Aspects of Schizophrenia Molecular Pathophysiology: Role of the Postsynaptic Density, and Implications for Treatment

    Article • Current Neuropharmacology, May 2014, Bentham Science Publishers

    Prof Andrea de Bartolomeis

  27. The Glucocorticoid Analog Dexamethasone Alters the Expression and the Distribution of Dopamine Receptors and Enkephalin within Cortico- Subcortical Regions

    Article • Current Molecular Pharmacology, April 2014, Bentham Science Publishers

    Prof Andrea de Bartolomeis

  28. Poster #T100 MINOCYCLINE ADD-ON TO HALOPERIDOL BLUNTS HALOPERIDOL-MEDIATED EXPRESSION OF EARLY GENES IMPLICATED IN GLUTAMATERGIC NEUROTRANSMISSION IN BOTH VEHICLE AND KETAMINE-TREATED RATS

    Article • Schizophrenia Research, April 2014, Elsevier

    Prof Andrea de Bartolomeis

  29. Poster #M252 PATIENTS' OPINIONS ON KEY ISSUES OF PSYCHOSOCIAL FUNCTIONING AMONG NON-PSYCHOTICS PSYCHOTIC RESPONDERS AND NON-RESPONDERS: CORRELATION WITH CLINICAL VARIABLES AND SYMPTOM DOMAINS RELEVANT TO REMISSION FROM PSYCHOSIS

    Article • Schizophrenia Research, April 2014, Elsevier

    Prof Andrea de Bartolomeis

  30. Poster #S257 TOUCHING BY HAND HOW PSYCHOTIC FEATURES TRANSLATE INTO WORSE LIFE CONDITIONS: THE RELATION OF KEY PSYCHOSOCIAL ISSUES WITH CLINICAL VARIABLES IN NON-PSYCHOTIC, PSYCHOTIC RESPONDER, AND PSYCHOTIC NON-RESPONDER PATIENTS

    Article • Schizophrenia Research, April 2014, Elsevier

    Prof Andrea de Bartolomeis

  31. The emerging role of dopamine–glutamate interaction and of the postsynaptic density in bipolar disorder pathophysiology: Implications for treatment

    Article • Journal of Psychopharmacology, February 2014, SAGE Publications

    Prof Andrea de Bartolomeis

  32. Patients with Poor Response to Antipsychotics Have a More Severe Pattern of Frontal Atrophy: A Voxel-Based Morphometry Study of Treatment Resistance in Schizophrenia

    Article • BioMed Research International, January 2014, Hindawi Publishing Corporation

    Prof Andrea de Bartolomeis

  33. EPA-1116 - Obesity affects cognitive performances even in the absence of obvious psychopathological alterations. a comparison with schizophrenia subjects and non-affected controls

    Article • European Psychiatry, January 2014, Elsevier

    Prof Andrea de Bartolomeis

  34. Efficacy and Clinical Determinants of Antipsychotic Polypharmacy in Psychotic Patients Experiencing an Acute Relapse and Admitted to Hospital Stay: Results from a Cross-Sectional and a Subsequent Longitudinal Pilot Study

    Article • ISRN Pharmacology, January 2014, Hindawi Publishing Corporation

    Prof Andrea de Bartolomeis

  35. EPA-1118 - Knowledge of the illness and its relations with quality of life, social functioning, cognitive performances, and adherence in psychotic patients: Toward effectiveness-focused interventions

    Article • European Psychiatry, January 2014, Elsevier

    Prof Andrea de Bartolomeis

  36. Differential Adaptive Changes in Dopaminergic System by Acute vs. Subchronic Ketamine: Relevance for Psychosis Pathophysiology and Treatment

    Article • Current Signal Transduction Therapy, December 2013, Bentham Science Publishers

    Prof Andrea de Bartolomeis

  37. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: Correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses

    Article • Psychiatry Research, December 2013, Elsevier

    Prof Andrea de Bartolomeis

  38. Imaging brain gene expression profiles by antipsychotics: Region-specific action of amisulpride on postsynaptic density transcripts compared to haloperidol

    Article • European Neuropsychopharmacology, November 2013, Elsevier

    Prof Andrea de Bartolomeis

  39. Affective temperaments are associated with specific clusters of symptoms and psychopathology: A cross-sectional study on bipolar disorder inpatients in acute manic, mixed, or depressive relapse

    Article • Journal of Affective Disorders, November 2013, Elsevier

    Prof Andrea de Bartolomeis

  40. P.1.g.054 Gene-expression imaging by N-methyl-D-aspartate receptor antagonists: implications for dopamine–glutamate interplay in psychosis

    Article • European Neuropsychopharmacology, October 2013, Elsevier

    Prof Andrea de Bartolomeis

  41. Intracellular pathways of antipsychotic combined therapies: Implication for psychiatric disorders treatment

    Article • European Journal of Pharmacology, October 2013, Elsevier

    Prof Andrea de Bartolomeis

  42. Decreased levels of d-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia

    Article • Journal of Psychiatric Research, October 2013, Elsevier

    Prof Andrea de Bartolomeis

  43. Glutamatergic Postsynaptic Density Protein Dysfunctions in Synaptic Plasticity and Dendritic Spines Morphology: Relevance to Schizophrenia and Other Behavioral Disorders Pathophysiology, and Implications for Novel Therapeutic Approaches

    Article • Molecular Neurobiology, September 2013, Springer Science + Business Media

    Prof Andrea de Bartolomeis

  44. Tobacco smoking in treatment-resistant schizophrenia patients is associated with impaired cognitive functioning, more severe negative symptoms, and poorer social adjustment

    Article • Neuropsychiatric Disease and Treatment, August 2013, Taylor & Francis

    Prof Andrea de Bartolomeis

  45. The Role of Intranasal Oxytocin in the Treatment of Patients with Schizophrenia: A Systematic Review

    Article • CNS & Neurological Disorders - Drug Targets, April 2013, Bentham Science Publishers

    Prof Andrea de Bartolomeis

  46. 2251 – Cortical and subcortical gene-expression imaging by different n-methyl-daspartate receptor (nmda-r) antagonists at glutammatergic synapses: implications for dopamine-glutamate interplay in psychoses

    Article • European Psychiatry, January 2013, Elsevier

    Prof Andrea de Bartolomeis

  47. Serotonin–glutamate and serotonin–dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins

    Article • Psychopharmacology, November 2012, Springer Science + Business Media

    Prof Andrea de Bartolomeis

  48. P.3.c.043 Resistance to antipsychotics is associated with higher cognitive impairment compared to non-resistant schizophrenia

    Article • European Neuropsychopharmacology, October 2012, Elsevier

    Prof Andrea de Bartolomeis

  49. Scaffolding Proteins of the Post-synaptic Density Contribute to Synaptic Plasticity by Regulating Receptor Localization and Distribution: Relevance for Neuropsychiatric Diseases

    Article • Neurochemical Research, September 2012, Springer Science + Business Media

    Prof Andrea de Bartolomeis

  50. Combination of aripiprazole with mood stabilizers for the treatment of bipolar disorder: from acute mania to long-term maintenance

    Article • Expert Opinion on Pharmacotherapy, September 2012, Informa Healthcare

    Prof Andrea de Bartolomeis

  51. Calcium-Dependent Networks in Dopamine–Glutamate Interaction: The Role of Postsynaptic Scaffolding Proteins

    Article • Molecular Neurobiology, July 2012, Springer Science + Business Media

    Prof Andrea de Bartolomeis

  52. Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor

    Article • European Neuropsychopharmacology, July 2012, Elsevier

    Prof Andrea de Bartolomeis

  53. The expression of genes involved in glucose metabolism is affected by N-methyl-D-aspartate receptor antagonism: A putative link between metabolism and an animal model of psychosis

    Article • Journal of Neuroscience Research, May 2012, Wiley

    Prof Andrea de Bartolomeis

  54. Clozapine impairs insulin action by up-regulating AKT phosphorylation and Ped/Pea-15 protein abundance

    Article • Journal of Cellular Physiology, January 2012, Wiley

    Prof Andrea de Bartolomeis

  55. Group 1 metabotropic glutamate receptors and schizophrenia

    Article • Wiley Interdisciplinary Reviews Membrane Transport and Signalling, October 2011, Wiley

    Prof Andrea de Bartolomeis

  56. Striatal expression of Homer1a is affected by genotype but not dystonic phenotype of tottering mice: A model of spontaneously occurring motor disturbances

    Article • Neuroscience Letters, October 2011, Elsevier

    Prof Andrea de Bartolomeis

  57. Weight Gain, Schizophrenia and Antipsychotics: New Findings from Animal Model and Pharmacogenomic Studies

    Article • Schizophrenia Research and Treatment, January 2011, Hindawi Publishing Corporation

    Prof Andrea de Bartolomeis

  58. The acute and chronic effects of combined antipsychotic–mood stabilizing treatment on the expression of cortical and striatal postsynaptic density genes

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, January 2011, Elsevier

    Prof Andrea de Bartolomeis

  59. P03-62 - Opioidergic system and N-methyl D-aspartate receptor (NMDA-R) hypofunction: Translational implications for the pathophysiology of psychosis and drug addiction

    Article • European Psychiatry, January 2011, Elsevier

    Prof Andrea de Bartolomeis

  60. Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions

    Article • Psychiatry Research, May 2010, Elsevier

    Prof Andrea de Bartolomeis

  61. Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes

    Article • Journal of Psychopharmacology, February 2010, SAGE Publications

    Prof Andrea de Bartolomeis

  62. Dopamine receptor subtypes contribution to Homer1a induction: Insights into antipsychotic molecular action

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, August 2009, Elsevier

    Prof Andrea de Bartolomeis

  63. Antipsychotic and antidepressant co-treatment: Effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders

    Article • Brain Research Bulletin, April 2009, Elsevier

    Prof Andrea de Bartolomeis

  64. HOMER1 Promoter Analysis in Parkinson’s Disease: Association Study with Psychotic Symptoms

    Article • Neuropsychobiology, January 2009, Karger Publishers

    Prof Andrea de Bartolomeis

  65. Association of antipsychotic induced weight gain and body mass index with GNB3 gene: A meta-analysis

    Article • Progress in Neuro-Psychopharmacology and Biological Psychiatry, December 2008, Elsevier

    Prof Andrea de Bartolomeis, Dr. Renan Pedra de Souza

  66. Analysis of Posttransplant Diabetes Mellitus Prevalence in a Population of Kidney Transplant Recipients

    Article • Transplantation Proceedings, July 2008, Elsevier

    Prof Andrea de Bartolomeis

  67. P.1.17 Topographical and temporal distribution of Homer1a expression is correlated to antipsychotics dopaminergic profile

    Article • European Neuropsychopharmacology, March 2008, Elsevier

    Prof Andrea de Bartolomeis

  68. Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: Implication for glutamatergic postsynaptic density in antipsychotics action

    Article • Neuroscience, November 2007, Elsevier

    Prof Andrea de Bartolomeis

  69. Ketamine-related expression of glutamatergic postsynaptic density genes: Possible implications in psychosis

    Article • Neuroscience Letters, April 2007, Elsevier

    Prof Andrea de Bartolomeis

  70. Prediction of antipsychotics gene targets by integration of genomic, evolutionary, and gene expression data

    Article • European Psychiatry, March 2007, Elsevier

    Prof Andrea de Bartolomeis

  71. Trp64Arg beta3 adrenergic polymorphism in antipsychotic-induced weight gain and obesity: A meta-analysis

    Article • European Psychiatry, March 2007, Elsevier

    Prof Andrea de Bartolomeis

  72. Association of the HTR2C gene and antipsychotic induced weight gain: a meta-analysis

    Article • The International Journal of Neuropsychopharmacology, February 2007, Oxford University Press (OUP)

    Prof Andrea de Bartolomeis

  73. Differential expression ofHomer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain

    Article • Synapse, January 2007, Wiley

    Prof Andrea de Bartolomeis

  74. Ferrous-Citrate Complex and Nigral Degeneration: Evidence for Free-radical Formation and Lipid Peroxidationa

    Article • Annals of the New York Academy of Sciences, December 2006, Wiley

    Prof Andrea de Bartolomeis

  75. Long-Term Outcome of Renal Transplantation From Marginal Donors

    Article • Transplantation Proceedings, December 2006, Elsevier

    Prof Andrea de Bartolomeis

  76. Gene–gene interaction between MAOA and COMT in suicidal behavior: Analysis in schizophrenia

    Article • Brain Research, June 2006, Elsevier

    Prof Andrea de Bartolomeis

  77. Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behaviour in schizophrenia

    Article • European Neuropsychopharmacology, May 2006, Elsevier

    Prof Andrea de Bartolomeis

  78. Dopamine-Glutamate Interaction and Antipsychotics Mechanism of Action: Implication for New Pharmacological Strategies in Psychosis

    Article • Current Pharmaceutical Design, October 2005, Bentham Science Publishers

    Prof Andrea de Bartolomeis

  79. Permanent Focal Brain Ischemia Induces Isoform-Dependent Changes in the Pattern of Na+/Ca2+ Exchanger Gene Expression in the Ischemic Core, Periinfarct Area, and Intact Brain Regions

    Article • Journal of Cerebral Blood Flow & Metabolism, August 2005, SAGE Publications

    Prof Andrea de Bartolomeis

  80. Cytomegalovirus Infection With Multiple Colonic Perforations in a Renal Transplant Recipient

    Article • Transplantation Proceedings, July 2005, Elsevier

    Prof Andrea de Bartolomeis

  81. Antidepressants activate CaMKII in neuron cell body by Thr286 phosphorylation

    Article • Neuroreport, October 2004, Wolters Kluwer Health

    Prof Andrea de Bartolomeis

  82. Postsynaptic density scaffolding proteins at excitatory synapse and disorders of synaptic plasticity: implications for human behavior pathologies

    Article • January 2004, Elsevier

    Prof Andrea de Bartolomeis

  83. Method for quantitative in situ hybridization histochemistry and image analysis applied for Homer1a gene expression in rat brain

    Article • Brain Research Protocols, July 2003, Elsevier

    Prof Andrea de Bartolomeis

  84. The forgotten therapy: Depot neuroleptics in the era of atypical antipsychotics, a community based study

    Article • Schizophrenia Research, March 2003, Elsevier

    Prof Andrea de Bartolomeis, Professor Salvatore Gentile

  85. Antipsychotics with different D2 dopamine receptor potency affect differently the postsynaptic density protein homer at glutamatergic metabotropic synapse

    Article • Schizophrenia Research, March 2003, Elsevier

    Prof Andrea de Bartolomeis

  86. Selective regulation of presynaptic Calcium/Calmodulin-Dependent protein kinase II by psychotropic drugs

    Article • Biological Psychiatry, March 2003, Elsevier

    Prof Andrea de Bartolomeis

  87. Decreased gene expression of calretinin and ryanodine receptor type 1 in tottering mice

    Article • Brain Research Bulletin, October 2002, Elsevier

    Prof Andrea de Bartolomeis

  88. Acute administration of antipsychotics modulates Homer striatal gene expression differentially

    Article • Molecular Brain Research, January 2002, Elsevier

    Prof Andrea de Bartolomeis

  89. NMDA receptor hypofunction: Cortical and subcortical CaMKII mRNA gene expression

    Article • European Neuropsychopharmacology, January 2001, Elsevier

    Prof Andrea de Bartolomeis

  90. Postsynaptic density protein gene expression after typical or atypical antipsychotics administration

    Article • Schizophrenia Research, January 2000, Elsevier

    Prof Andrea de Bartolomeis

  91. Simian virus-40 large-T antigen binds p53 in human mesotheliomas

    Article • Nature Medicine, August 1997, Nature

    Prof Andrea de Bartolomeis

  92. Opioidergic and dopaminergic gene expression in the caudate-putamen and accumbens of the mutant mouse, tottering (tg/tg)

    Article • Molecular Brain Research, June 1997, Elsevier

    Prof Andrea de Bartolomeis

  93. Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous Infusion

    Article • Journal of Cerebral Blood Flow & Metabolism, April 1997, SAGE Publications

    Prof Andrea de Bartolomeis

  94. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography method

    Article • Proceedings of the National Academy of Sciences, March 1997, Proceedings of the National Academy of Sciences

    Prof Andrea de Bartolomeis

  95. In vivo estimates of synaptic dopamine concentrations with 11C-raclopride/pet: A direct test of the dopamine hypothesis

    Article • Schizophrenia Research, April 1995, Elsevier

    Prof Andrea de Bartolomeis

  96. Lack of effect of chronic morphine treatment and naloxone-precipitated withdrawal on tyrosine hydroxylase, galanin, and neuropeptide Y mRNA levels in the rat locus coeruleus

    Article • Synapse, March 1995, Wiley

    Prof Andrea de Bartolomeis

  97. Dopaminergic and peptidergic mRNA levels in juvenile rat brain after prenatal cocaine treatment

    Article • Molecular Brain Research, February 1994, Elsevier

    Prof Andrea de Bartolomeis

  98. Dopaminergic regulation of epileptic activity

    Article • Neurochemistry International, March 1992, Elsevier

    Prof Andrea de Bartolomeis

  99. Plasma HVA, tardive dyskinesia and psychotic symptoms in long-term drug-free inpatients with schizophrenia

    Article • Psychiatry Research, September 1990, Elsevier

    Prof Andrea de Bartolomeis

  100. Plasma HVA in schizophreniform disorder and chronic schizophrenia

    Article • Schizophrenia Research, January 1989, Elsevier

    Prof Andrea de Bartolomeis

  101. Survey on Schizophrenia

    Article • American Psychological Association (APA)

    Prof Andrea de Bartolomeis